Skip to main content

UBS Group AG

Position in OVID — Ovid Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in OVID

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,234,486
+$618,092 QoQ
Shares Held
458,917
+65.3% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OVID Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. OVID ranks #254 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OVID

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,234,486 458,917
2026-03-31 $616,394 277,656
2025-12-31 $314,564 192,985
2025-09-30 $309,372 237,979
2025-06-30 $7,150 21,669
2025-03-31 $8,410 26,958
2024-12-31 $56,755 60,767
2024-09-30 $36,122 30,612
2024-06-30 $16,296 21,192
2024-03-31 $223,936 73,422
2023-12-31 $231,624 71,933
2023-09-30 $184,730 48,107
2023-06-30 $162,773 49,626
2023-03-31 $46,617 18,069
2022-12-31 $31,234 16,793
2022-09-30 $35,256 19,161
2022-06-30 $34,281 15,945
2022-03-31 $47,100 15,000
2021-12-31 $61,879 19,277
2021-09-30 $50,400 15,000
2021-06-30 $58,650 15,000
2021-03-31 $80,548 20,037
2020-12-31 $2,378,359 1,029,593
2020-09-30 $2,584,554 450,271
2020-06-30 $980,135 132,990
2020-03-31 $619,731 207,964